This proposal investigates how histone lysine demethylase LSD2 is targeted and retained to actively transcribed gene bodies by its cofactor NPAC. We hypothesize that NPAC has dual interactions with LSD2 via NPAC's linker region and the H3K36me3 histone modification- containing nucleosomes via NPAC's PWWP domain, thereby physically linking LSD2 to H3K36me3-enriched functional sites. We will employ various NPAC mutation and deletion constructs and use molecular biological and biochemical approaches to determine the molecular mechanism underlying NPAC-mediated targeting of LSD2 to its functional sites. Results from the proposed study will offer significant insight into the molecular mechanism by which NPAC contributes to LSD2 mediated gene regulation within actively transcribed gene bodies. If successful, the proposal is expected to offer new insight into our understanding of the role and mechanism of action of cofactors in regulation of histone demethylation, and make significant impact on the advancement of epigenetic gene regulation and chromatin biology. Ultimately, findings from the proposed study will also provide important information for the development of epigenetic-based therapeutics.

Public Health Relevance

Determining how histone lysine demethylation is targeted and regulated is pressingly needed for our understanding of epigenetic abnormality-caused disease processes such as cancer and enabling clinical translational research for disease treatment. Thus the proposed research will have significant public health impact because it is relevant to NIH's mission of developing fundamental knowledge that is required to explore epigenetics-based therapeutics to alleviate human illnesses.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Carter, Anthony D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Larson, Allison R; Dresser, Karen A; Zhan, Qian et al. (2014) Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Mod Pathol 27:936-44
Chen, Fei; Yang, Huirong; Dong, Zhenghong et al. (2013) Structural insight into substrate recognition by histone demethylase LSD2/KDM1b. Cell Res 23:306-9
Fang, Rui; Chen, Fei; Dong, Zhenghong et al. (2013) LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation. Mol Cell 49:558-70
Tan, Li; Xiong, Lijun; Xu, Wenqi et al. (2013) Genome-wide comparison of DNA hydroxymethylation in mouse embryonic stem cells and neural progenitor cells by a new comparative hMeDIP-seq method. Nucleic Acids Res 41:e84
Lian, Christine Guo; Xu, Yufei; Ceol, Craig et al. (2012) Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135-46
Xu, Yufei; Xu, Chao; Kato, Akiko et al. (2012) Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 151:1200-13
Gu, Tian-Peng; Guo, Fan; Yang, Hui et al. (2011) The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477:606-10
Xu, Yufei; Wu, Feizhen; Tan, Li et al. (2011) Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42:451-64
Pojoga, Luminita H; Williams, Jonathan S; Yao, Tham M et al. (2011) Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol 301:H1862-71
Zhang, Haikuo; Zhang, Xin; Clark, Erin et al. (2010) TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res 20:1390-3

Showing the most recent 10 out of 11 publications